Tag: Cardiogenic Shock

Improving Outcomes with Impella Platform

This course is specifically for Surgeons, Heart Failure and Interventional Cardiologists (Heart Team) that treat patients with cardiogenic shock with a primary focus on survival with native heart recovery.

Improving Survival in Cardiogenic Shock by Adopting a Uniform Approach to Systems of Care

Reference: J Am Coll Cardiol 2018; 72:1972-80   Cardiogenic shock continues to be the leading cause of death in patients with acute myocardial infarction (AMI).1 Despite implementation of guideline-recommended early revascularization, mortality rates in AMI complicated by cardiogenic shock (AMICS) remains constant at about 50%. Given that about 60,000 patients with AMI develop CS every … Continue reading “Improving Survival in Cardiogenic Shock by Adopting a Uniform Approach to Systems of Care”

The Door-to-Unloading (DTU) STEMI Safety & Feasibility Trial

Navin Kapur, MD, executive director of the CardioVascular Center for Research and Innovation at Tufts Medical Center, discusses the results of the FDA STEMI Door-to-Unloading safety and feasibility randomized controlled trial. These results were presented at the American Heart Association Scientific Sessions 2018 in Chicago on Sunday, November 11. What did we learn from this pilot … Continue reading “The Door-to-Unloading (DTU) STEMI Safety & Feasibility Trial”

National Cardiogenic Shock Initiative: 1 Year Later

Video Chapters: The Impact of The Cardiogenic Shock Initiative (NCSI): One Year Later William O’Neill, MD Advances in the Treatment of Cardiovascular Disease in Women: PCI, MI, Shock, Myocarditis, SCAD, and Post-partum Cardiomyopathy Cindy Grines, MD Understanding the Importance of Ventricular Unloading in Management of AMI and Cardiogenic Shock Navin Kapur, MD Subscribe, or join the … Continue reading “National Cardiogenic Shock Initiative: 1 Year Later”

Cardiogenic Shock Due to Severe Multi-Vessel Disease

Dr. Alexander Truesdell, Interventional Cardiologist from Inova Heart & Vascular Institute, presents a case of cardiogenic shock, involving a 69 year old patient with severe multi-vessel disease and co-morbidities, EF between 10 and 15% and a severely depressed cardiac index. Prior to proceeding with PCI, the Impella CP was implanted to provide hemodynamic support. Once … Continue reading “Cardiogenic Shock Due to Severe Multi-Vessel Disease”

Heart Team Approach to Treating Cardiogenic Shock

Dr. Alexander Truesdell of INOVA Heart and Vascular Institute compares his experience in combat medicine and combat medical care to the cardiogenic shock scenario. Best practices based on the team’s real-world experience treating cardiogenic shock include: One-call system for shock call Multidisciplinary team including cardiac surgeons, interventional cardiologists and heart failure specialists Rapid, collaborative decision-making … Continue reading “Heart Team Approach to Treating Cardiogenic Shock”

Exchanging a Balloon Pump with the Impella CP® Heart Pump: Case Review

In this case presentation, Dr. Shon (Anjan) Chakrabarti of the Sentara Heart Hospital in Norfolk, VA, discusses the use of the Impella CP® device in a 62-year-old woman with obesity, diabetes, and hypertension who required escalation from a previously placed balloon pump. Due to multivessel disease, the patient was deemed too high risk for bypass … Continue reading “Exchanging a Balloon Pump with the Impella CP® Heart Pump: Case Review”